Skip to main content

Incyte Milestone and contract revenues

  • INCY · Nasdaq
  • Biotechnology
  • S&P 500
$120.97−0.60%Close 13 Nov 2026 · Market value $24.66B

Milestone and contract revenues at Incyte came to $49.8M for the quarter to 30 Sep 2026, up 10.7% from a year earlier.

As Incyte reported it in its earnings release and quarterly or annual report, compiled and checked by AapWire. Latest figure filed 29 Oct 2026.

By quarter

$0Jun 2023$5.0MSep 2023$2.0MDec 2023$25.0MMar 2024$0Jun 2024$18.0MSep 2024$0Mar 2025$5.0MJun 2025$45.0MSep 2025$17.0MMar 2026$11.2MJun 2026$49.8MSep 2026
Incyte Milestone and contract revenues, every reported period
Period endingMilestone and contract revenuesChange on a yearFiled
30 Sep 2026$49.8Mup 10.7%29 Oct 2026
30 Jun 2026$11.2Mup 124.0%28 Jul 2026
31 Mar 2026$17.0M—28 Apr 2026
30 Sep 2025$45.0Mup 150.0%28 Oct 2025
30 Jun 2025$5.0M—29 Jul 2025
31 Mar 2025$0down 100.0%29 Apr 2025
30 Sep 2024$18.0Mup 260.0%29 Oct 2024
30 Jun 2024$0—30 Jul 2024
31 Mar 2024$25.0M—30 Apr 2024
31 Dec 2023$2.0Mdown 93.3%13 Feb 2024
30 Sep 2023$5.0M—31 Oct 2023
30 Jun 2023$0down 100.0%1 Aug 2023
31 Mar 2023$0down 100.0%2 May 2023
31 Dec 2022$30.0M—7 Feb 2023
30 Sep 2022$0down 100.0%1 Nov 2022
30 Jun 2022$130.0Mup 1200.0%2 Aug 2022
31 Mar 2022$5.0M—3 May 2022
30 Sep 2021$35.0M—2 Nov 2021
30 Jun 2021$10.0Mdown 89.5%3 Aug 2021
31 Dec 2020$110.0M—9 Feb 2021
30 Sep 2020$0down 100.0%5 Nov 2020
30 Jun 2020$95.0Mup 375.0%4 Aug 2020
31 Mar 2020$0down 100.0%5 May 2020
31 Dec 2019$0down 100.0%13 Feb 2020
30 Sep 2019$17.5Mdown 12.5%29 Oct 2019
30 Jun 2019$20.0Mdown 80.0%30 Jul 2019
31 Mar 2019$40.0M—30 Apr 2019
31 Dec 2018$60.0Mdown 14.3%14 Feb 2019
30 Sep 2018$20.0Mup 33.3%30 Oct 2018
30 Jun 2018$100.0M—31 Jul 2018
31 Mar 2018$0down 100.0%1 May 2018
31 Dec 2017$70.0M—15 Feb 2018
30 Sep 2017$15.0M—31 Oct 2017
30 Jun 2017$0—1 Aug 2017
31 Mar 2017$90.0M—4 May 2017

Definition

Revenue from this part of the business, as the company names and reports it in its results. Each figure is read from the table or sentence the company printed and kept with its scale and decimals; see data and methodology.

Other operating KPIs of Incyte: Customer A (change on a year) · Customer B (change on a year) · Customer C (change on a year) · JAKAFI revenue · OPZELURA revenue · Product royalty revenues · JAKAVI revenue · NIKTIMVO revenue · ZYNYZ revenue · MINJUVI/MONJUVI revenue · OLUMIANT revenue · ICLUSIG revenue · PEMAZYRE revenue · TABRECTA revenue · United States revenue · Europe revenue · financial statements

Every KPI and segment of INCY, in the terminal.

Ten years of operating figures, segments, guidance against results, charts and alerts on each new release.